CSS LLC’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,900
Closed -$2.15M 736
2022
Q4
$2.15M Buy
27,900
+2,000
+8% +$120K 0.12% 164
2022
Q3
$1.16M Sell
25,900
-15,800
-38% -$789K 0.05% 313
2022
Q2
$1.6M Buy
41,700
+17,800
+74% +$563K 0.07% 331
2022
Q1
$989K Sell
23,900
-2,300
-9% -$71.3K 0.04% 441
2021
Q4
$990K Buy
26,200
+1,700
+7% +$62.5K 0.04% 433
2021
Q3
$807K Buy
+24,500
New +$955K 0.03% 479
2021
Q2
Sell
-4,400
Closed -$249K 1078
2021
Q1
$249K Sell
4,400
-7,300
-62% -$514K 0.01% 718
2020
Q4
$953K Buy
11,700
+200
+2% +$15K 0.04% 328
2020
Q3
$820K Buy
11,500
+500
+5% +$39K 0.04% 334
2020
Q2
$905K Sell
11,000
-3,300
-23% -$254K 0.05% 286
2020
Q1
$842K Sell
14,300
-41,700
-74% -$3.4M 0.07% 229
2019
Q4
$5.79M Buy
+56,000
New +$2.26M 0.32% 69

Other funds holding AXSM